Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.

Biotechnology

Mnemo Therapeutics

Mariana Gajardo

Christine Foster

Bénédicte Balland

Nadia Kaci-Chaouche

Bertrand Vannier

Nil Ege

Michael Saitakis

The Scientific Team at Mnemo Therapeutics is responsible for conducting cutting-edge research to identify and validate new therapeutic targets for solid tumors and blood cancers. This multidisciplinary team leverages expertise in molecular biology, bioinformatics, computational biology, proteomics, immunology, and cell biology to develop and optimize the company's innovative EnfiniT platform. Their efforts aim to discover novel antigens and improve T cell therapies' memory, persistence, and sensitivity, driving the advancement of powerful immune therapies to provide accessible cures for patients.

Scientific Team

Leadership Team

Scientific and Laboratory Operations

Scientific Team

About

Team members